We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
Encompass Health
EHC
$12B
| $14K | ﹤0.01% |
204
| – | – |
2022 Q1
7 quarters
|
|
927
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$3.99B
| $14K | ﹤0.01% |
600
| – | – |
2023 Q2
2 quarters
|
|
|
MCR
928
DELISTED
MFS Charter Income Trust
MCR
| $14K | ﹤0.01% |
2,225
| – | – |
2022 Q1
7 quarters
|
|
929
Pembina Pipeline
PBA
$29.1B
| $14K | ﹤0.01% |
400
| – | – |
2022 Q1
7 quarters
|
|
930
Restaurant Brands International
QSR
$26.3B
| $14K | ﹤0.01% |
177
| – | – |
2022 Q1
7 quarters
|
|
931
Roku
ROKU
$23.3B
| $14K | ﹤0.01% |
+150
| New | +$12.5K |
2023 Q4
0 quarters
|
|
932
Saic
SAIC
$5.59B
| $14K | ﹤0.01% |
111
+100
| +909% | +$11.6K |
2022 Q1
7 quarters
|
|
933
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$866M
| $14K | ﹤0.01% |
1,400
| – | – |
2023 Q3
1 quarter
|
|
934
Travel + Leisure Co
TNL
$4.07B
| $14K | ﹤0.01% |
347
| – | – |
2022 Q1
7 quarters
|
|
935
WD-40
WDFC
$2.71B
| $14K | ﹤0.01% |
57
| – | – |
2022 Q2
6 quarters
|
|
|
PUB
936
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
| $14K | ﹤0.01% |
619
| – | – |
2022 Q1
7 quarters
|
|
937
A10 Networks
ATEN
$1.79B
| $13K | ﹤0.01% |
1,000
| – | – |
2022 Q1
7 quarters
|
|
938
Alibaba
BABA
$271B
| $13K | ﹤0.01% |
160
+130
| +433% | +$10.4K |
2022 Q1
7 quarters
|
|
939
Chemours
CC
$1.93B
| $13K | ﹤0.01% |
391
-30
| -7% | -$814 |
2023 Q2
2 quarters
|
|
940
WisdomTree Emerging Currency Strategy Fund
CEW
$19.8M
| $13K | ﹤0.01% |
750
| – | – |
2023 Q3
1 quarter
|
|
941
DTE Energy Company 2017 Series E 5.25% Junior Subordinated Debentures due 2077
DTW
$290M
| $13K | ﹤0.01% |
+541
| New | +$12.1K |
2023 Q4
0 quarters
|
|
942
Hyatt Hotels
H
$16.4B
| $13K | ﹤0.01% |
100
| – | – |
2022 Q1
7 quarters
|
|
943
The Hartford Insurance Group 6.000% Series G Preferred Stock
HIG.PRG
$306M
| $13K | ﹤0.01% |
+530
| New | +$12.9K |
2023 Q4
0 quarters
|
|
944
JPMorgan Equity Premium Income ETF
JEPI
$46.1B
| $13K | ﹤0.01% |
+240
| New | +$12.9K |
2023 Q4
0 quarters
|
|
945
Western Asset Managed Municipals Fund
MMU
$523M
| $13K | ﹤0.01% |
+1,313
| New | +$12.4K |
2023 Q4
0 quarters
|
|
946
VanEck Agribusiness ETF
MOO
$1.1B
| $13K | ﹤0.01% |
176
| – | – |
2022 Q2
6 quarters
|
|
947
DELISTED
BlackRock MuniVest Fund II
MVT
| $13K | ﹤0.01% |
1,167
| – | – |
2022 Q1
7 quarters
|
|
948
Saratoga Investment
SAR
$231M
| $13K | ﹤0.01% |
500
| – | – |
2023 Q2
2 quarters
|
|
949
Bio-Techne
TECH
$11.4B
| $13K | ﹤0.01% |
+172
| New | +$11.3K |
2023 Q4
0 quarters
|
|
950
DELISTED
Stericycle Inc
SRCL
| $13K | ﹤0.01% |
260
-250
| -49% | -$11.2K |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.